Cas:130061-28-8 Perindoprilat Lactam B manufacturer & supplier

Chemical Name:Perindoprilat Lactam B

CAS.NO:130061-28-8

Synonyms:Perindopril Related Compound D;(2S)-2-[(3S,5aS,9aS,10aR)-3-methyl-1,4-dioxo-5a,6,7,8,9,9a,10,10a-octahydro-3H-pyrazino[1,2-a]indol-2-yl]pentanoic acid;Perindopril Impurity 4

Molecular Formula:C₁₇H₂₆N₂O₄

Molecular Weight:322.39900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.25±0.1 g/cm3

Index of Refraction:

PSA:77.92000

Exact Mass:322.18900

LogP:1.50590

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Perindopril Related Compound D chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Perindopril Impurity 4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-2-[(3S,5aS,9aS,10aR)-3-methyl-1,4-dioxo-5a,6,7,8,9,9a,10,10a-octahydro-3H-pyrazino[1,2-a]indol-2-yl]pentanoic acid Use and application,Perindopril Related Compound D technical grade,usp/ep/jp grade.

Related News: Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access. Perindoprilat Lactam B manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. Perindoprilat Lactam B supplier Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space. Perindoprilat Lactam B vendor The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. Perindoprilat Lactam B factory Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access.